Announcement
Vanda Pharmaceuticals Announces the Publication of an Article "Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"
Vanda Pharmaceuticals
PR-02-25-NI-25Feb 24, 2025
Collaboration
Regenacy Pharmaceuticals Announces Collaboration with the Charcot-Marie-Tooth Association (CMTA) to Advance Ricolinostat for the Treatment of Hereditary Neuropathy
Regenacy Pharmaceuticals
PR-M08-18-NI-044Aug 13, 2018